Main Menu
Menu

Resources

Publish Date
Resources
Letters
C4IP Letter to USTR on US-EU Trade Agreement, 12/4/2025
Resources
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Resources
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Resources
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
C4IPResources
Letters
C4IP Letter to Senate and House IP Subcommittees on Designating October as National IP Month

Dear Chairmen Tillis and Issa and Ranking Members Schiff and Johnson: On behalf of the Council for Innovation Promotion (C4IP), I write...

Resources
Letters
C4IP Letter to Senate Judiciary IP Subcommittee on PERA Hearing
Resources
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Resources
Letters
C4IP Letter to House Judiciary IP Subcommittee on Artificial Intelligence
Resources
Letters
C4IP Letter to FTC & DOJ on Drug Pricing Listening Sessions
Resources
Infographics & Fact Sheets
Drug Competition Enhancement Act Infographic
Resources:

Resources:

Affordable Prescriptions for Patients Act Infographic,

06/27/2025
Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025
Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025
Resources:

Resources:

Drug Competition Enhancement Act,

06/25/2025
Resources:

Resources:

Affordable Prescriptions for Patients Act,

06/24/2025
Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025
Resources:

Resources:

The Congressional Innovation Scorecard: Second Edition,

06/10/2025
Resources:

Resources:

C4IP Letter to OSTP on IP and Innovation,

05/09/2025
Resources:

Resources:

C4IP Letter to Senators Thom Tillis and Chris Coons on PERA and PREVAIL Act,

05/01/2025
Resources:

Resources:

C4IP Letter to European Commission on the General Pharmaceutical Legislation and Patent Package,

04/23/2025
Resources:

Resources:

C4IP Letter to Administration on 2022 PTAB Guidance Withdrawal and Interim Guidelines,

04/18/2025
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on 4/3 Hearing,

04/02/2025
Scroll to Top